Homes of Excellence Healthcare Limited Filleted accounts for Companies House (small and micro)

Homes of Excellence Healthcare Limited Filleted accounts for Companies House (small and micro)


0 false false false false false false false false false true false false false false false false No description of principal activity 2020-03-12 Sage Accounts Production Advanced 2020 - FRS102_2019 976,413 976,413 976,413 xbrli:pure xbrli:shares iso4217:GBP 12513139 2020-03-12 2021-08-31 12513139 2021-08-31 12513139 bus:Director1 2020-03-12 2021-08-31 12513139 bus:Director2 2020-03-12 2021-08-31 12513139 core:WithinOneYear 2021-08-31 12513139 core:ShareCapital 2021-08-31 12513139 core:AdditionsToInvestments core:Non-currentFinancialInstruments 2021-08-31 12513139 core:CostValuation core:Non-currentFinancialInstruments 2021-08-31 12513139 core:Non-currentFinancialInstruments 2021-08-31 12513139 bus:SmallEntities 2020-03-12 2021-08-31 12513139 bus:AuditExempt-NoAccountantsReport 2020-03-12 2021-08-31 12513139 bus:FullAccounts 2020-03-12 2021-08-31 12513139 bus:SmallCompaniesRegimeForAccounts 2020-03-12 2021-08-31 12513139 bus:PrivateLimitedCompanyLtd 2020-03-12 2021-08-31
COMPANY REGISTRATION NUMBER: 12513139
Homes of Excellence Healthcare Limited
Filleted Unaudited Financial Statements
31 August 2021
Homes of Excellence Healthcare Limited
Statement of Financial Position
31 August 2021
31 Aug 21
Note
£
Fixed assets
Investments
4
976,413
Current assets
Debtors
5
15,254
Cash at bank and in hand
2,208
--------
17,462
Creditors: amounts falling due within one year
6
993,775
---------
Net current liabilities
976,313
---------
Total assets less current liabilities
100
----
Capital and reserves
Called up share capital
100
----
Shareholders funds
100
----
These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with Section 1A of FRS 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland'.
In accordance with section 444 of the Companies Act 2006, the statement of comprehensive income has not been delivered.
For the period ending 31 August 2021 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
Directors' responsibilities:
- The members have not required the company to obtain an audit of its financial statements for the period in question in accordance with section 476 ;
- The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of financial statements .
These financial statements were approved by the board of directors and authorised for issue on 8 December 2021 , and are signed on behalf of the board by:
Mr N J Askew
Mr C P Sheppard
Director
Director
Company registration number: 12513139
Homes of Excellence Healthcare Limited
Notes to the Financial Statements
Period from 12 March 2020 to 31 August 2021
1. General information
The company is a private company limited by shares, registered in England and Wales. The address of the registered office is 5 The Quadrant, Coventry, CV1 2EL, West Midlands.
2. Statement of compliance
These financial statements have been prepared in compliance with Section 1A of FRS 102, 'The Financial Reporting Standard applicable in the UK and the Republic of Ireland'.
3. Accounting policies
Basis of preparation
The financial statements have been prepared on the historical cost basis, as modified by the revaluation of certain financial assets and liabilities and investment properties measured at fair value through profit or loss.
The financial statements are prepared in sterling, which is the functional currency of the entity.
Revenue recognition
Turnover is measured at the fair value of the consideration received or receivable and represents amounts receivable for recharges to group.
Investments
Fixed asset investments are initially recorded at cost, and subsequently stated at cost less any accumulated impairment losses.
Listed investments are measured at fair value with changes in fair value being recognised in profit or loss.
Impairment of fixed assets
A review for indicators of impairment is carried out at each reporting date, with the recoverable amount being estimated where such indicators exist. Where the carrying value exceeds the recoverable amount, the asset is impaired accordingly. Prior impairments are also reviewed for possible reversal at each reporting date. For the purposes of impairment testing, when it is not possible to estimate the recoverable amount of an individual asset, an estimate is made of the recoverable amount of the cash-generating unit to which the asset belongs. The cash-generating unit is the smallest identifiable group of assets that includes the asset and generates cash inflows that largely independent of the cash inflows from other assets or groups of assets. For impairment testing of goodwill, the goodwill acquired in a business combination is, from the acquisition date, allocated to each of the cash-generating units that are expected to benefit from the synergies of the combination, irrespective of whether other assets or liabilities of the company are assigned to those units.
Financial instruments
A financial asset or a financial liability is recognised only when the entity becomes a party to the contractual provisions of the instrument. Basic financial instruments are initially recognised at the transaction price, unless the arrangement constitutes a financing transaction, where it is recognised at the present value of the future payments discounted at a market rate of interest for a similar debt instrument. Debt instruments are subsequently measured at amortised cost.
4. Investments
Shares in group undertakings
£
Cost
At 12 March 2020
Additions
976,413
---------
At 31 August 2021
976,413
---------
Impairment
At 12 March 2020 and 31 August 2021
---------
Carrying amount
At 31 August 2021
976,413
---------
5. Debtors
31 Aug 21
£
Amounts owed by group undertakings and undertakings in which the company has a participating interest
15,254
--------
6. Creditors: amounts falling due within one year
31 Aug 21
£
Amounts owed to group undertakings and undertakings in which the company has a participating interest
993,775
---------